GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Euro-Med Laboratories Philippines Inc (PHS:EURO) » Definitions » Change In Receivables

Euro-Med Laboratories Philippines (PHS:EURO) Change In Receivables : ₱-316 Mil (TTM As of Dec. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Euro-Med Laboratories Philippines Change In Receivables?

Euro-Med Laboratories Philippines's change in receivables for the quarter that ended in Dec. 2024 was ₱17 Mil. It means Euro-Med Laboratories Philippines's Accounts Receivable declined by ₱17 Mil from Sep. 2024 to Dec. 2024 .

Euro-Med Laboratories Philippines's change in receivables for the fiscal year that ended in Dec. 2024 was ₱-316 Mil. It means Euro-Med Laboratories Philippines's Accounts Receivable increased by ₱316 Mil from Dec. 2023 to Dec. 2024 .

Euro-Med Laboratories Philippines's Accounts Receivable for the quarter that ended in Dec. 2024 was ₱1,807 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Euro-Med Laboratories Philippines's Days Sales Outstanding for the three months ended in Dec. 2024 was 95.57.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Euro-Med Laboratories Philippines's liquidation value for the three months ended in Dec. 2024 was ₱-1,740 Mil.


Euro-Med Laboratories Philippines Change In Receivables Historical Data

The historical data trend for Euro-Med Laboratories Philippines's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euro-Med Laboratories Philippines Change In Receivables Chart

Euro-Med Laboratories Philippines Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 183.71 211.04 -64.71 -187.32 -316.16

Euro-Med Laboratories Philippines Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 230.27 107.79 -186.79 -253.99 16.82

Euro-Med Laboratories Philippines Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₱-316 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euro-Med Laboratories Philippines  (PHS:EURO) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Euro-Med Laboratories Philippines's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1807.412/1725.771*91
=95.57

2. In Ben Graham's calculation of liquidation value, Euro-Med Laboratories Philippines's accounts receivable are only considered to be worth 75% of book value:

Euro-Med Laboratories Philippines's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1100.55-5067.005+0.75 * 1807.412+0.5 * 1741.724
=-1,740

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euro-Med Laboratories Philippines Change In Receivables Related Terms

Thank you for viewing the detailed overview of Euro-Med Laboratories Philippines's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Euro-Med Laboratories Philippines Business Description

Traded in Other Exchanges
N/A
Address
San Marcelino Street, 1000 United Nations Avenue corner Street, PPL Building, 2nd floor, Manila, PHL, 1000
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for the injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis.

Euro-Med Laboratories Philippines Headlines

No Headlines